Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.
Kinyua AW. et al, (2024), The Journal of infection, 89
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M. et al, (2024), Life science alliance, 7
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Nkumama IN. et al, (2024), Immunity, 57, 1215 - 1224.e6
Social, Ethical and Regulatory implications of conducting a malaria Vaccine Efficacy trial in a human infection study in Kenya (SERVE-Kenya): A study protocol
Chi PC. et al, (2024), Wellcome Open Research, 9, 193 - 193
Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.
Kapulu MC. et al, (2024), Frontiers in immunology, 15
The Dantu blood group prevents parasite growth in vivo: Evidence from a controlled human malaria infection study.
Kariuki SN. et al, (2023), eLife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera DO. et al, (2023), Science translational medicine, 15
Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya.
Sang S. et al, (2023), Wellcome open research, 8
Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL. et al, (2023), Expert review of vaccines, 22, 964 - 1007
Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
Kapulu MC. et al, (2022), BMC Infectious Diseases, 22
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.
Musasia FK. et al, (2022), Nature communications, 13
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Williams E. et al, (2022), Vaccine, 40, 3484 - 3489
Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.
Chi PC. et al, (2022), BMC medical ethics, 23
Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study.
Kimingi HW. et al, (2022), Frontiers in immunology, 13
Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.
Kapulu MC. et al, (2022), Frontiers in immunology, 13
Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt.
Mumba N. et al, (2022), Frontiers in public health, 10
Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia
Kunda-Ng'andu EM. et al, (2021), Wellcome Open Research, 6, 31 - 31
Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
Kapulu MC. et al, (2021), JCI Insight, 6
Equity for excellence in academic institutions: a manifesto for change
Wedekind L. et al, (2021), Wellcome Open Research, 6, 142 - 142